CIK 0000062709 · Large accelerated filer
MARSH & MCLENNAN COMPANIES, INC.
Sign in to watch- Ticker
- MRSH
- Exchange
- NYSE
- Industry
- Insurance Agents, Brokers & Service
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 362668272
- Phone
- 2123455000
- Business address
- 1166 AVENUE OF THE AMERICAS, NEW YORK, NY, 10036
- Former names
- MARSH & MCLENNAN COMPANIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,598,243
- in 5 filings, $4.4M under 10b5-1 plans
Net −$4,598,243. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Doyle John Q −$3.1M President and CEO sold 12% of stake
- Klisura Dean Michael −$839K President & CEO, Marsh RE sold 17% of stake
- Mills Stacy −$243K Vice President and Controller sold 31% of stake
- Brennan Katherine −$225K SVP and General Counsel sold 14% of stake
- Beswick Paul −$152K SVP, Chief Information Officer sold 4% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-01 | Doyle John Q President and CEO | Option exercise 10b5-1 | +21,079 | $63.09 | $1.3M | 108,760.02 |
| 2025-12-01 | Doyle John Q President and CEO | Sale 10b5-1 | −21,079 | $182.22 | $3.8M | 87,681.02 |
| 2025-12-01 | Doyle John Q President and CEO | Option exercise · Stock Options (Right to Buy) 10b5-1 | −21,079 | 0 | ||
| 2025-11-15 | SCHAPIRO MORTON O Director | Grant or award · Restricted Stk. Units-Dir. Stk. Plan | +225.07 | $183.28 | $41K | 87,649.88 |
| 2025-11-15 | Yates Lloyd M Director | Grant or award · Restricted Stk. Units-Dir. Stk. Plan | +197.78 | $183.28 | $36K | 10,491.67 |
| 2025-11-15 | Lute Jane H Director | Grant or award · Restricted Stk. Units-Dir. Stk. Plan | +148.34 | $183.28 | $27K | 7,157.45 |
| 2025-11-15 | MILLS STEVEN A Director | Grant or award | +231 | $183.28 | $42K | 3,900.75 |
| 2025-11-14 | SCHAPIRO MORTON O Director | Other acquisition · Restricted Stk. Units-Dir. Stk. Plan | +426.84 | $183.44 | $78K | 87,424.81 |
| 2025-11-14 | Anderson Anthony Director | Other acquisition · Restricted Stk. Units-Dir. Stk. Plan | +75.99 | $183.44 | $14K | 15,563.68 |
| 2025-11-14 | HOPKINS DEBORAH C Director | Other acquisition · Restricted Stk. Units-Dir. Stk. Plan | +96.91 | $183.44 | $18K | 19,849.64 |
| 2025-11-14 | Ingram Tamara Director | Other acquisition · Restricted Stk. Units-Dir. Stk. Plan | +37.37 | $183.44 | $7K | 7,653.6 |
| 2025-11-14 | Yates Lloyd M Director | Other acquisition · Restricted Stk. Units-Dir. Stk. Plan | +50.26 | $183.44 | $9K | 10,293.89 |
| 2025-11-14 | Lute Jane H Director | Other acquisition · Restricted Stk. Units-Dir. Stk. Plan | +34.22 | $183.44 | $6K | 7,009.11 |
| 2025-11-14 | Siegmund Jan Director | Other acquisition · Restricted Stk. Units-Dir. Stk. Plan | +4.58 | $183.44 | $840 | 938.25 |
| 2025-09-02 | Doyle John Q President and CEO | Option exercise 10b5-1 | +21,079 | $63.09 | $1.3M | 108,760.02 |
| 2025-09-02 | Doyle John Q President and CEO | Sale 10b5-1 | −21,079 | $205.65 | $4.3M | 87,681.02 |
| 2025-09-02 | Doyle John Q President and CEO | Option exercise · Stock Options (Right to Buy) 10b5-1 | −21,079 | 21,079 | ||
| 2025-08-15 | Anderson Anthony Director | Other acquisition · Restricted Stk. Units-Dir. Stk. Plan | +66.71 | $208.06 | $14K | 15,487.69 |
| 2025-08-15 | HOPKINS DEBORAH C Director | Other acquisition · Restricted Stk. Units-Dir. Stk. Plan | +85.08 | $208.06 | $18K | 19,752.73 |
| 2025-08-15 | Yates Lloyd M Director | Grant or award · Restricted Stk. Units-Dir. Stk. Plan | +174.23 | $208.06 | $36K | 10,200.26 |
Page 8 of 9 · 165 trades